Recruitment for Area Manager in Leading Pharma Company- Nextus | 07 Posts
Leading Pharma Company- Nextus
Post: Area Manager
Eisai Inc. and Arena Pharmaceuticals, Inc. announced that the Federal Commission for the Protection Against Sanitary Risk has granted regulatory approval of the chronic weight management agent VENESPRI® for commercialization by Eisai Laboratorios in Mexico.
The U.S. Food and Drug Administration has approved an expanded indication for Synjardy® (empagliflozin and metformin hydrochloride) tablets to include treatment-naïve adults with type 2 diabetes (T2D). SYNJARDY, from Boehringer Ingelheim and Eli Lilly and Company, is indicated as an adjunct to diet and exercise to improve glycemic control in adults with T2D when treatment with both empagliflozin and metformin is appropriate.
Cerulean Pharma, a clinical-stage company developing nanoparticle-drug conjugates (NDCs), announced that the U.S. Food and Drug Administration (FDA) granted Fast Track designation for Cerulean's lead nanoparticle-drug conjugate, CRLX101, in combination with paclitaxel, for the treatment of platinum-resistant ovarian carcinoma, fallopian tube or primary peritoneal cancer.